AIBioTech buys ImmunoTox; PPD adds an exec;

> Virgina's AIBioTech has purchased ImmunoTox, a CRO focused on immunotoxicology and immunopharmacology studies. More

> PPD has appointed Biogen Idec ($BIIB) veteran Michael Pollock to serve as its vice president of real-world outcomes. Item

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.